Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Rockcliff Energy III Acquires East Texas Assets from Pine Wave Energy Partners
Kirkland & Ellis has advised Rockcliff Energy III LLC, a portfolio company of Quantum Capital Group, while Akin advised Pine Wave Energy Partners. Rockcliff Energy III...
Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion
Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics. Novo Nordisk has entered into a definitive agreement to acquire Akero...
Argano Acquires Twelve Consulting Group
Kirkland & Ellis has advised Argano on the transaction, and Messerli Kramer has advised Twelve Consulting Group. Argano, a digital services consultancy specializing in optimizing business...
Knox Lane’s Partnership with HCEsquared
Kirkland & Ellis represented Knox Lane, while Shulman Rogers LLP represented HCEsquared. Knox Lane, a growth-oriented investment firm, announced its significant strategic investment in Healthcare Experts...
General Catalyst and HATCo’s Acquisition of Summa Health
Kirkland & Ellis is advising General Catalyst and Health Assurance Transformation, LLC (HATCo) on the transaction. General Catalyst and Health Assurance Transformation, LLC (HATCo) announced the proposed...
Gallatin Point’s Partnership with American Family Insurance
Kirkland & Ellis advised Gallatin Point Capital on the transaction, and Willkie Farr and Gallagher advised American Family. Gallatin Point Capital LLC (Gallatin Point) announced a partnership with...
Arch Capital Group’s Acquisition of Old Republic’s Mortgage Insurance Business
Kirkland & Ellis is advising Old Republic International Corporation on the transaction. Old Republic International Corporation (NYSE:ORI) announced that it has entered into a definitive agreement to...
































